Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Dietary counseling
ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and dual glucose-dependent insulinotropic polypeptide/GLP-1 RAs are common therapies for managing diabetes and obesity, but gastrointestinal (GI) adverse effects (AEs) such as nausea, vomiting, diarrhea, and constipation frequently limit therapy
De Leo E, Taranta A, Raso R, Polishchuk E, DOria V, Pezzullo M, Goffredo BM, Cairoli S, Bellomo F, Battafarano G, Camassei FD, Del Fattore A, Polishchuk R, Emma F, Rega LR (2023) Genistein improves renal disease in a mouse model of nephropathic cystinosis: a comparison study with cysteamine
Immediate consequences of acute kidney injury: The impact of traditional and nontraditional complications on mortality in acute kidney injury
Irregular sleep and cardiometabolic risk: Clinical evidence and mechanisms
US$ 20.06
US$ 26.50
US$ 29.86
US$ 27.04
US$ 23.87
US$ 26.89
US$ 27.23
US$ 26.69
US$ 20.96
US$ 21.37
US$ 21.73
US$ 26.32
US$ 28.73
